Experimental parathyroid hormone gene therapy using ØC31 integrase

Endocrine Journal

Volumn 55, Issue 6, 2008, Pages 1033-1041

  Lee, Sihoon ^a,b   Hong, Soon Won ^c   Choi, Han Seok ^c   Lee, Lee Young ^a   Nam, Chunja ^d   Rhee, Yumie ^c   Chung, Ung Il ^b   Lim, Sung Kil ^c  

^a Gachon University   (South Korea)

^b UNIVERSITY OF TOKYO   (Japan)

^c Yonsei University College of Medicine   (South Korea)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

C31 integrase; Gene therapy; Hypoparathyroidism; Parathyroid hormone

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; INTEGRASE; PARATHYROID HORMONE; PHIC31 INTEGRASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GENE THERAPY; GENE TRANSFER; HORMONE RELEASE; HUMAN; HUMAN CELL; HYDRODYNAMICS BASED TRANSFECTION; HYPOPARATHYROIDISM; IMMUNORADIOMETRIC ASSAY; MALE; MOUSE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PLASMID; PROTEIN EXPRESSION;

ANIMALS; ATTACHMENT SITES, MICROBIOLOGICAL; BACTERIOPHAGES; CELLS, CULTURED; CULTURE MEDIA; GENE THERAPY; HUMANS; HYPOPARATHYROIDISM; INTEGRASES; LIVER; MALE; MICE; MICE, INBRED ICR; MODELS, THEORETICAL; MUTAGENESIS, INSERTIONAL; PARATHYROID HORMONE; TREATMENT OUTCOME;

EID: 58549090319     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-040     Document Type: Article

References (22)

1. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, et al. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
2. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
3. Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, Hillman RT, et al. (2006) Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol 357: 28-48.
4. Groth AC, Calos MP (2004) Phage integrases: biology and applications. J Mol Biol 335: 667-678.
5. Calos MP (2006) The phiC31 integrase system for gene therapy. Curr Gene Ther 6: 633-645.
6. Goswami R, Mohapatra T, Gupta N, Rani R, Tomar N, Dikshit A, et al. (2004) Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism. J Clin Endocrinol Metab 89: 4840-4845.
7. Pallotti F, Seregni E, Ferrari L, Martinetti A, Biancolini D, Bombardieri E (2003) Diagnostic and therapeutic aspects of iatrogenic hypoparathyroidism. Tumori 89: 547-549.
8. Romijn JA, Smit JW, Lamberts SW (2003) Intrinsic imperfections of endocrine replacement therapy. Eur J Endocrinol 149: 91-97.
9. Gardella TJ, Axelrod D, Rubin D, Keutmann HT, Potts JT, Jr., Kronenberg HM, et al. (1991) Mutational analysis of the receptor-activating region of human parathyroid hormone. J Biol Chem 266: 13141-13146.
10. Groth AC, Olivares EC, Thyagarajan B, Calos MP (2000) A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci USA 97: 5995-6000.
11. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21: 3926-3934.
12. Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP (2002) Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 20: 1124-1128.
13. Tabor S, Richardson CC (1985) A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc Natl Acad Sci USA 82: 1074-1078.
14. Combes P, Till R, Bee S, Smith MC (2002) The streptomyces genome contains multiple pseudo-attB sites for the (phi)C31-encoded site-specific recombination system. J Bacteriol 184: 5746-5752.
15. Thorpe HM, Smith MC (1998) In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci USA 95: 5505-5510.
16. Thorpe HM, Wilson SE, Smith MC (2000) Control of directionality in the site-specific recombination system of the Streptomyces phage phiC31. Mol Microbiol 38: 232-241.
17. Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755.
18. Portlock JL, Keravala A, Bertoni C, Lee S, Rando TA, Calos MP (2006) Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Hum Gene Ther 17: 871-876.
19. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, et al. (2002) Stable nonviral genetic correction of inherited human skin disease. Nat Med 8: 1166-1170.
20. Liu F, Song Y, Liu D (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266.
21. Zhang G, Budker V, Wolff JA (1999) High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10: 1735-1737.
22. Goodman WG (2004) Calcium-sensing receptors. Semin Nephrol 24: 17-24.